Medical Devices
-
Scientists urge EPA not to weaken ethylene oxide emissions standards
Scientists, clinicians and residents of communities near medical device sterilization plants called for the EPA not to weaken its oversight of ethylene oxide in a public hearing.
By Elise Reuter • April 3, 2026 -
Restore Robotics cleared to remanufacture 2 more da Vinci Xi instruments
The remanufacturer said it now has a total of four clearances for Intuitive Surgical da Vinci instruments from the Food and Drug Administration.
By Susan Kelly • April 3, 2026 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Merit Medical acquires View Point for $140M
View Point sells tumor tissue localization devices that could complement Merit’s existing presence in the sector.
By Nick Paul Taylor • April 2, 2026 -
J&J’s Impella heart pump shows no patient benefit in 2 trials
Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat heart attack patients who don’t have cardiogenic shock.
By Susan Kelly • April 1, 2026 -
Deep Dive
‘Cracks show’ as CDRH staff contend with heavy workloads
Former device leaders said a culture of “fear and anxiety” has driven experienced staff from the Food and Drug Administration. An overburdened workforce has affected communications from the agency.
By Elise Reuter , Shaun Lucas • April 1, 2026 -
Distalmotion targets ASC robotic gynecology programs with FDA filing
The company is seeking clearance in additional gynecological indications to support outpatient use of its surgical robot.
By Nick Paul Taylor • April 1, 2026 -
Whoop raises $575M, adds Abbott as strategic investor
Whoop, the maker of a wearable wristband, plans to use the funds for global expansion and personalized health features.
By Elise Reuter • March 31, 2026 -
Medtronic wins CE mark for OmniaSecure defibrillation lead
The device maker designed the lead to have the safety benefits of small-diameter devices without sacrificing durability.
By Nick Paul Taylor • March 31, 2026 -
Medtronic to study renal denervation combined with PCI
Medtronic detailed plans to further study the blood pressure treatment while releasing additional data from the SPYRAL HTN trials that showed the procedure reduced hypertensive emergencies.
By Susan Kelly • March 31, 2026 -
Boston Scientific posts positive stroke prevention data for Watchman
The company said it will seek an expanded indication for the left atrial appendage closure device after it met all safety and efficacy goals in the closely watched CHAMPION-AF study.
By Susan Kelly • March 30, 2026 -
Medtronic wins FDA clearance for robot in cranial, ENT surgeries
The surgical navigation and robotics system is part of the company’s push to expand its share of the $15 billion cranial and spinal technologies market.
By Nick Paul Taylor • March 30, 2026 -
Glucotrack plans US trial of implantable glucose monitor this year
Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the second half of 2026.
By Elise Reuter • March 27, 2026 -
Philips wins FDA clearance for imaging device developed with Edwards
The system uses AI to optimize the placement of Edwards’ mitral valve repair device.
By Nick Paul Taylor • March 27, 2026 -
Endologix to close production facility, lay off 31 people
The company acquired the facility in the PQ Bypass takeover it struck in the aftermath of its bankruptcy filing.
By Nick Paul Taylor • March 26, 2026 -
Retrieved from NASA's Moderate Resolution Imaging Spectroradiometer.
Manufacturers brace for price increases from Strait of Hormuz closure
Crude oil prices have surged 47% this month and polypropylene jumped 24%, affecting transportation and plastics costs.
By Nathan Owens • March 26, 2026 -
CMR Surgical robot builds momentum ahead of US rollout
CMR Surgical is formally introducing its Versius robot at a surgeons’ meeting this week in what CEO Massimiliano Colella described as a “watershed moment” for the company.
By Susan Kelly • March 26, 2026 -
Meet 6 medtech companies redefining surgical robotics
Executives at companies innovating a range of new robotic surgery platforms shared their progress and challenges in MedTech Dive's series of profiles.
By Susan Kelly • Updated March 25, 2026 -
Medtronic lowers earnings forecast after MiniMed IPO
The timing of the initial public offering and the clearance of a new insulin pump are expected to affect Medtronic’s results for its 2026 fiscal year.
By Elise Reuter • March 25, 2026 -
Medtronic’s OmniaSecure defibrillation lead earns expanded FDA indication
The OmniaSecure lead gained the first U.S. approval for placement in the heart’s left bundle branch area, to help activate the natural electrical system.
By Susan Kelly • March 25, 2026 -
Medtronic to distribute Merit Medical’s low back pain treatment
Merit’s basivertebral nerve ablation system is expected to round out Medtronic’s pain treatment options.
By Elise Reuter • March 24, 2026 -
SS Innovations ramps up in telesurgery; XCath robot treats stroke remotely
SS Innovations’ robot won approvals to perform telesurgery in Indonesia and the Philippines, while the first remote robotic mechanical thrombectomy to treat stroke was performed with XCath’s system.
By Susan Kelly • March 24, 2026 -
GE HealthCare wins FDA nod for photon-counting CT technology
The 510(k) decision clears the company to challenge Siemens Healthineers for an emerging part of the CT imaging sector.
By Nick Paul Taylor • March 24, 2026 -
FTC creates healthcare task force
The task force will share resources and coordinate enforcement across the Federal Trade Commission’s disparate bureaus to better address consumer protection and competition issues in healthcare, the FTC commissioner said.
By Rebecca Pifer Parduhn • March 23, 2026 -
Retrieved from Owen Mumford on March 19, 2026
Embecta to buy Owen Mumford for up to $201M
The planned purchase would allow Embecta to serve patients outside of diabetes care.
By Elise Reuter • March 19, 2026 -
JenaValve snags FDA approval in aortic regurgitation
The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.
By Susan Kelly • March 18, 2026